0.7729
price down icon0.27%   -0.0021
after-market アフターアワーズ: .75 -0.0229 -2.96%
loading
前日終値:
$0.775
開ける:
$0.85
24時間の取引高:
14.71M
Relative Volume:
11.82
時価総額:
$74.06M
収益:
-
当期純損益:
$-93.61M
株価収益率:
-0.3663
EPS:
-2.11
ネットキャッシュフロー:
$-71.16M
1週間 パフォーマンス:
+13.65%
1か月 パフォーマンス:
-30.99%
6か月 パフォーマンス:
-36.65%
1年 パフォーマンス:
-38.17%
1日の値動き範囲:
Value
$0.725
$0.8735
1週間の範囲:
Value
$0.625
$0.8735
52週間の値動き範囲:
Value
$0.561
$2.11

Immunic Inc Stock (IMUX) Company Profile

Name
名前
Immunic Inc
Name
セクター
Healthcare (1168)
Name
電話
(332) 255-9818
Name
住所
1200 AVENUE OF THE AMERICAS, NEW YORK
Name
職員
90
Name
Twitter
@ImmunicInc
Name
次回の収益日
2025-03-17
Name
最新のSEC提出書
Name
IMUX's Discussions on Twitter

IMUX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IMUX
Immunic Inc
0.7729 65.17M 0 -93.61M -71.16M -2.11
Biotechnology icon
ONC
Beone Medicines Ltd Adr
257.00 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.82 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.282 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
85.54 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
483.07 65.36B 14.09B 4.50B 2.96B 39.28

Immunic Inc Stock (IMUX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-25 開始されました William Blair Outperform
2024-11-25 開始されました H.C. Wainwright Buy
2024-09-09 再開されました Leerink Partners Outperform
2024-08-27 開始されました B. Riley Securities Buy
2022-10-21 ダウングレード SVB Leerink Outperform → Mkt Perform
2022-09-19 再開されました H.C. Wainwright Buy
2021-04-15 開始されました Aegis Capital Buy
2021-03-24 開始されました JMP Securities Mkt Outperform
2020-10-02 開始されました SVB Leerink Outperform
2020-08-26 開始されました Piper Sandler Overweight
2020-08-07 再開されました ROTH Capital Buy
2020-07-20 開始されました BMO Capital Markets Outperform
2020-06-05 開始されました Wedbush Outperform
2020-05-11 開始されました H.C. Wainwright Buy
2020-03-25 開始されました ROTH Capital Buy
2019-07-11 開始されました Chardan Capital Markets Buy
すべてを表示

Immunic Inc (IMUX) 最新ニュース

pulisher
Jun 05, 2025

Immunic at Jefferies Conference: Promising MS Drug Insights - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

Small cap wrap: Midnight Sun Mining, Standard Uranium, Immunic, ReconAfrica... - Proactive Investors

Jun 05, 2025
pulisher
Jun 05, 2025

Market movers: Tesla, Verint, PVH, Immunic... - Proactive financial news

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic (IMUX) Receives Continued 'Buy' Rating from D. Boral Cap - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic completes patient enrollment in Phase 3 relapsing multiple sclerosis trials - Proactive financial news

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic Completes Enrollment in 2 Phase 3 Studies in Relapsing Multiple Sclerosis - marketscreener.com

Jun 05, 2025
pulisher
Jun 05, 2025

IMUX: Promising Results of Vidofludimus Calcium in Multiple Sclerosis Treatment | IMUX Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

IMUX Completes Enrollment for Phase 3 Trials in Multiple Scleros - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS | IMUX S - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS - Yahoo Finance

Jun 05, 2025
pulisher
Jun 04, 2025

Top Executives Make Bold Moves with Major Immunic Stock Purchases! - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Immunic Approves Equity Plan Amendment at Annual Meeting - TipRanks

Jun 04, 2025
pulisher
Jun 03, 2025

Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering | IMUX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Immunic Announces Closing Of Oversubscribed $65 Million Underwritten Public Offering - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering - Longview News-Journal

Jun 03, 2025
pulisher
Jun 03, 2025

Immunic raises $65M in public offering to fund clinical trials - Proactive financial news

Jun 03, 2025
pulisher
Jun 02, 2025

Immunic to Participate in Investor, Scientific and Industry Conf - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Immunic Showcases Breakthrough MS Drug Data at 6 Major Healthcare Conferences This Month - Stock Titan

Jun 02, 2025
pulisher
Jun 02, 2025

Immunic releases June conference schedule - Proactive Investors

Jun 02, 2025
pulisher
May 30, 2025

Immunic Announces $65 Million Public Offering - TipRanks

May 30, 2025
pulisher
May 30, 2025

Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - Eastern Progress

May 30, 2025
pulisher
May 30, 2025

Immunic Inc. prices $65 million public offering By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 30, 2025

Immunic (NASDAQ:IMUX) Price Target Lowered to $10.00 at D. Boral Capital - Defense World

May 30, 2025
pulisher
May 29, 2025

Immunic (IMUX) Launches $65M Public Offering, Shares Drop - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic Tumbles After Pricing $65 Million Offering of Warrants - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Un - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Small cap wrap: Fineqia, Synchronoss, Santacruz Silver, Immunic... - Proactive financial news

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Receives Target Price Adjustment from D. Boral Ca - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Faces Price Target Reduction Amid Stock Offering - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Faces Price Target Reduction Amid Stock Offering | IMUX Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Launches Public Offering with Warrant Options | I - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic shares fall 12% after pricing of $65 million underwritten public offering to fund trials - Seeking Alpha

May 29, 2025
pulisher
May 29, 2025

Immunic to raise up to $65M in underwritten public offering - Proactive Investors

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Launches Public Offering with Warrant Options | IMUX Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic Announces Pricing Of Oversubscribed $65 Million Underwritten Public Offering - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Immunic Inc. prices $65 million public offering - Investing.com

May 29, 2025
pulisher
May 29, 2025

Immunic, Inc. Announces Proposed Public Offering - Longview News-Journal

May 29, 2025
pulisher
May 29, 2025

Immunic Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - Investing.com Nigeria

May 29, 2025
pulisher
May 28, 2025

Immunic launches public offering of warrants to fund clinical trials; shares down - MSN

May 28, 2025
pulisher
May 28, 2025

Immunic slides on planned equity raise - TradingView

May 28, 2025
pulisher
May 28, 2025

Immunic (IMUX) Launches Public Offering with Pre-Funded and Warr - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Immunic announces public offering of warrants to fund trials By Investing.com - Investing.com India

May 28, 2025
pulisher
May 28, 2025

Immunic (IMUX) Launches Public Offering with Pre-Funded and Warrants | IMUX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Immunic Announces Public Offering to Fund Trials - TipRanks

May 28, 2025
pulisher
May 28, 2025

Biotech Immunic Launches Strategic Public Offering to Advance Inflammatory Disease Pipeline - Stock Titan

May 28, 2025
pulisher
May 27, 2025

Immunic's IMU-856 shows promise as Celiac Disease Awareness Month draws to a close - Proactive Investors

May 27, 2025
pulisher
May 26, 2025

Immunic’s (IMUX) Buy Rating Reiterated at B. Riley - Defense World

May 26, 2025
pulisher
May 23, 2025

Analyst Adjusts Target Price for Immunic (IMUX) Amid Strategic F - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Immunic (IMUX) Price Target Lowered by B. Riley Securities | IMU - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Analyst Adjusts Target Price for Immunic (IMUX) Amid Strategic Financing Prospects | IMUX Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

B. Riley Cuts Price Target on Immunic to $5 From $6, Keeps Buy Rating - marketscreener.com

May 23, 2025

Immunic Inc (IMUX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Immunic Inc (IMUX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Rudick Richard Alan
Director
Jun 03 '25
Buy
0.70
143,075
100,024
230,375
Rudick Richard Alan
Director
Nov 12 '24
Buy
1.15
87,300
100,369
87,300
$1.15
price down icon 0.86%
$580.59
price up icon 1.24%
$308.00
price up icon 0.88%
$36.54
price up icon 1.27%
$4.8111
price up icon 1.29%
$483.07
price down icon 0.38%
大文字化:     |  ボリューム (24 時間):